Patents by Inventor Claude Jasmin

Claude Jasmin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for regulating hematopoietic cell differentiation with polymers containing disaccharide units
    Publication number: 20040204384
    Abstract: The invention concerns the use of a polymer comprising an efficient amount of
    Type: Application
    Filed: May 4, 2004
    Publication date: October 14, 2004
    Applicant: Institut National De La Sante Et De La Recherche Medial (Inserm)
    Inventors: Florence Smadja-Joffe, Rachida-Sihem Charrad, Christine Chomienne, Bertrand Delpech, Claude Jasmin
  • Means for regulating hematopoietic differentiation
    Publication number: 20030032621
    Abstract: The invention concerns the use of a polymer comprising an efficient amount of disaccharide units each consisting of a molecule with N-acetyl-D-glucosamine structure bound by the O-glucoside &bgr;1,4 linkage to a molecule with glucuronic acid structure for producing a medicine designed to induce or stimulate the differentiation of hematopoietic cells, and leukemic cells in particular.
    Type: Application
    Filed: August 13, 2001
    Publication date: February 13, 2003
    Inventors: Florence Smadja-Joffe, Rachida-Sihem Charrad, Christine Chomienne, Bertrand Delpech, Claude Jasmin
  • Recombinant production of a human interferon (IFN)-gamma antagonist cytokine
    Patent number: 5612195
    Abstract: A cytokine that is a specific antagonist of induction by interferon-gamma of the expression of class II histocompatibility antigens at the cell surface is disclosed. The cytokine is naturally secreted by cells or is the expression product of an exogenous DNA sequence in prokaryotic or eukaryotic cells. Also disclosed is a DNA sequence that codes, on expression in a host cell, for a cytokine having a biological activity that is a specific antagonist of induction by interferon-gamma of the expression of class II histocompatibility antigens at the cell surface. A method for preparing the cytokine is further disclosed. Finally, a therapeutic composition containing the cytokine is disclosed.
    Type: Grant
    Filed: August 29, 1994
    Date of Patent: March 18, 1997
    Assignee: Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Patricia Krief, Bruno Azzarone, Yvette Augery-Bourget, Claude Boucheix, Claude Jasmin
  • Apparatus for hyperthermic treatment
    Patent number: 4785829
    Abstract: The invention pertains to an apparatus for hyperthermic treatment, especially designed for deep hyperthermia. The treatment apparatus comprises at least two generators operating at different frequencies in such a way as to prevent any phase correlation between the waves delivered by the generators.
    Type: Grant
    Filed: December 3, 1986
    Date of Patent: November 22, 1988
    Assignee: C.G.R Mev
    Inventors: Guy Convert, Guy Azam, Jean P. Mabire, Claude Jasmin, Joel Sidi
  • Hyperthermia apparatus
    Patent number: 4572190
    Abstract: A hyperthermia apparatus primarily applicable to the treatment of tumors comprises at least three high-frequency generators connected to three electrodes. The electrodes are intended to be coupled to a patient's body which constitutes the load, thus producing a higher temperature rise in the vicinity of a fictitious electrode in the body. The generators have adjustable phases and amplitudes, the output of each generator being connected to each of the three electrodes.
    Type: Grant
    Filed: May 21, 1984
    Date of Patent: February 25, 1986
    Assignee: CGR/MEV
    Inventors: Guy Azam, Guy Convert, Jacques Dufour, Claude Jasmin, Joel Sidi
  • Antiviral agent
    Patent number: 4547369
    Abstract: Compounds containing the heteropolyanion 9-antimoni-III-21-tungsto VI sodate of the formula [NaSb.sub.9 W.sub.21 O.sub.86 ] preferably the ammonium, alkali and alkali metal salts thereof, are active when administered by injection against virus infections, particularly leukemia, sarcoma and encephalomyocardia virus, as shown, by tests in vitro and in vivo in mice.
    Type: Grant
    Filed: September 11, 1979
    Date of Patent: October 15, 1985
    Assignee: Cabinet Harle & Phelip
    Inventors: Jean-Claude Chermann, Claude Jasmin, Georges Mathe, Marcel Raynaud, deceased, Odette J. Raynaud, heir